American Enterprise Institute for Public Policy Research
Comparative Effectiveness Research: The Need for a Uniform Standard
June 2009
Reconciling a new comparative effectiveness research (CER) agency with scientific standards established in existing regulations would enable government agencies to share a consistent framework for making decisions based on CER. It would provide the kind of level playing field and clear guidelines that are needed to spur medical product developers and private payers to generate more of their own comparative evidence.
Reprinted with the permission of the American Enterprise Institute for Public Policy Research, Washington, D.C.
Capabilities
Suggested News & Insights
Sidley Represents Changchun GeneScience (GenSci) Pharmaceuticals in Its Strategic Licensing Agreement With Yarrow Bioscience for First-in-Class Autoimmune Thyroid Disease TherapyDecember 18, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025U.S. FDA's Adoption of ICH E6(R3) Good Clinical Practice: Key Takeaways for Sponsors and InvestigatorsDecember 4, 2025Sidley Represents PayRange in Its Acquisition of KioSoftDecember 1, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory